Note 6 - Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Accrued Liabilities and Other Current Liabilities Disclosure [Text Block]

(6) Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):             

	March 31,		December 31,
	2024		2023
Accrued expenses	$	116	$	75
Accrued salaries and employee benefits		837		661
Accrued clinical trial costs		1,140		1,017
Grant liability		471		471
Customer deposits		90		90
Payable to related party		42		71
Total	$	2,696	$	2,385